Blood Epidemiology and Clinical Therapeutics
Funding for benign blood diseases and cell therapies (e.g., hematopoietic stem cell transplants, transfusion products, and novel cell therapies), including development and dissemination of data science resources in patient-reported outcomes.
Program Officers
Nahed El Kassar, M.D., Ph.D.
Hematology, immunology; transfusion
301-435-0065